Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Streetwise Reports (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

PEA Due Out Next Month Should Improve Project Economics

% of readers think this story is Fact. Add your two cents.


Source: Hannam & Partners 08/23/2024

This is one of four key points Hannam & Partners makes about the gold-silver project based on its site visit, the investment bank noted in a report.

Thesis Gold Inc. (TAU:TSXV; THSGF:OTCQX; A3EP87:WKN) hosted Hannam & Partners at its Lawyers-Ranch gold-silver project in British Columbia on Aug. 13, and the analysts shared their takeaways in an Aug. 18 research note.

“We expect the shares to rerate as Thesis Gold continues to expand the size of Lawyers-Ranch through exploration whilst also advancing through to development,” the analysts wrote.

165% Return Potential

The investment bank has a CA$2.04 per share target valuation on Thesis, noted the analysts, which they would raise to CA$3.20 were a likely combined development to become the base case.

In comparison, the Canadian gold and silver explorer is trading now at about CA$0.77 per share, from which the return to the current target is 165%.

Project at a Glance

Hannam & Partners analysts described Thesis’ Lawyers-Ranch project. It is two projects in one, together spanning 352 square kilometers (352 sq km) and linked by a refurbished, permitted road. The current joint resource is 4 million ounces (Moz) of 1.51 grams per ton gold equivalent (1.51 g/t Au eq) in the Measured & Indicated category and 727,000 ounces (727 Koz) of 1.82 g/t Au eq in the Inferred category.

Lawyers comprises 46 contiguous claims over 14,392 hectares, and has a 0.5% royalty with Royal Gold Inc. (RGLD:NASDAQ; RGL:TSX) in play. To the north of Lawyers is 180-sq km Ranch, where a previous owner holds a 2% non-smelter return royalty.

Thesis also owns exploration licenses on property to the east of Ranch and is doing early exploration work there.

What to Know

The analysts shared these four key points about Lawyers-Ranch after their site visit:

1) The Lawyers-Ranch preliminary economic assessment (PEA), expected next month, should reveal enhanced project economics. Both Lawyers and Ranch will be covered in this version versus only Lawyers in the previous one. The new PEA will contain evaluations of an open-pit and underground mine at Lawyers and an open-pit operation at Ranch.

“We expect this to materially enhance the economics of the project, with our NAV for Lawyers-Ranch being 69% higher than for Lawyers alone,” the analysts wrote.

2) Exploration potential at Ranch should expand the combined resource.

Ranch is the main focus of Thesis Gold’s in-progress exploration program. There, the company is testing nine targets, following up on two previously drilled targets and potentially expanding the existing 681 Koz resource encompassing five surface mineralized zones: the Thesis Corridor, Bonanza Ridge, Bonanza South, JK and BV.

“We believe Ranch has the potential to ultimately be comparable to other large-scale, high-sulphidation epithermal systems and host a deposit several times larger than its current size,” the analysts commented.

3) Management is engaged with all stakeholder First Nations communities.

Thesis has an exploration cooperation and benefit agreement in place with the Tsay Keh Dene Nation, the Kwadacha Nation and the Takla Nation. With the Tahltan Nation, it has an exploration agreement. The company has formed a committee tasked with informing the groups about project updates and possible economic opportunities, which should help Thesis obtain the necessary project permits.

4) Project access and nearby infrastructure exist. These include water, power, a road, nearby town and airstrip.

Catalysts on the Horizon

In the near term, investors can expect events that could boost Thesis’ stock, Hannam & Partners reported.

One is the release of a completed PEA on Lawyers-Ranch due out this September. The other is drill results from the 2024 summer program at Ranch.

Sign up for our FREE newsletter at: www.streetwisereports.com/get-news

Important Disclosures:

  1. Thesis Gold Inc. is a billboard sponsor of Streetwise Reports and pays SWR a monthly sponsorship fee between US$4,000 and US$5,000.
  2. Doresa Banning wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an employee.
  3. This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.

For additional disclosures, please click here.

Disclosures for Hannam & Partners, Thesis Gold Aug. 19, 2024

This Document has been prepared by H&P Advisory Limited (“H&P”), which is authorised and regulated by the Financial Conduct Authority (Firm Reference Number 805667) and is incorporated in England & Wales with no. 11120795. The Document is protected by international copyright laws and may not be (i) copied, photocopied or duplicated in any form by any means or (ii) redistributed (in whole or in part) without H&P’s prior written permission. The information contained herein does not constitute an offer or solicitation to sell or acquire any security or fund the acquisition of any security by anyone in any jurisdiction where such an offer or solicitation would be illegal, nor should it be regarded as a contractual document. Under no circumstances should the information provided in this Document, or any other written or oral information made available in connection with it, be considered as investment advice or as a sufficient basis on which to make investment decisions. This Document does not constitute a personal recommendation and, if appropriate, you should seek professional advice, including tax advice, before making investments decisions.

The information in this Document does not purport to be comprehensive and has been provided by H&P (and, in certain cases, third party sources such as credit rating agencies) and has not been independently verified. The information set out herein and in any related materials reflects prevailing conditions and our views as at this date and is subject to updating, completion, revision, verification and amendment, and such information may change materially. H&P is under no obligation to provide the recipient with access to any additional information or to update this Document or any related materials or to correct any inaccuracies in it which may become apparent.

Marketing Communication

This Document does not represent investment research for the purposes of the rules of the Financial Conduct Authority (“FCA Rules”). To the extent it constitutes a research recommendation, it takes the form of NON-INDEPENDENT research for the purposes of the FCA Rules. As such it constitutes a MARKETING COMMUNICATION, has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of dissemination of investment research.

Statements Relating to Performance

All statements of opinion and/or belief contained in this Document and all views expressed and all projections, forecasts or statements regarding future events or possible future performance represent H&P’s own assessment and interpretation of information available to it as at the date of this Document. This Document and any related materials may include certain forward-looking statements, beliefs, or opinions. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There can be no assurance that any of the results and events contemplated by the forward-looking statements contained in the information can be achieved or will, in fact, occur. Past performance cannot be relied on as a guide to future performance.

Distribution Restrictions

This document is directed only at persons who: (i) are Qualified Investors within the meaning of Article 2(e) of Regulation (EU) 2017/1129, as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, (as amended); and (ii) have professional experience in matters relating to investments who fall within the definition of “Investment Professionals” contained in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the “Order”) or are persons falling within Article 49(2)(a) to (d) (High Net Worth Companies, Unincorporated Associations, etc.) of the Order, or fall within another exemption to the Order (all such persons referred to in (i) and (ii) above together being referred to as “Relevant Persons”). This Document is not intended for distribution to or use by any person or entity in any jurisdiction or country where such distribution or use would be contrary to local law or regulation and persons into whose possession this Document comes are required to inform themselves about, and observe, any such restrictions.

Valuation Assumptions/Risks

Please note our valuation estimates provide an assessment of the value of the issuer at a specific point in time, based on public information as well as assumptions and forecasts made by H&P, which are subject to change at any time. It should be noted that the prices of listed equities often deviate significantly from assessments of their fundamental value. Our valuation estimates should not be interpreted as a prediction of the price at which the issuer’s shares will trade in future.

Company/Issuer Disclosures

H&P may from time to time have a broking, corporate finance advisory, or other relationship with a company which is the subject of or referred to in the Document.

( Companies Mentioned: TAU:TSXV; THSGF:OTCQX; A3EP87:WKN, )


Source: https://www.streetwisereports.com/article/2024/08/23/pea-due-out-next-month-should-improve-project-economics.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Lion’s Mane Mushroom Nootropic

Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, But it benefits growth of Essential Gut Flora, further enhancing your Vitality.


 


Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity.


Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins.


Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system.


Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome.


Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function.


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.